Williams-Salmon v. Raheja

2022 Ohio 1675
Ohio Court of Appeals·Decided May 19, 2022·No. 110856 & 110928·Published·Cited by 1 cases

Opinion

COURT OF APPEALS OF OHIO

EIGHTH APPELLATE DISTRICT COUNTY OF CUYAHOGA

MARILYN WILLIAMS-SALMON :

Plaintiff-Appellee, :

Nos. 110856 and 110928

v. :

DEEPAK RAHEJA, M.D., ET AL., :

Defendants-Appellants. :

JOURNAL ENTRY AND OPINION

JUDGMENT: AFFIRMED

RELEASED AND JOURNALIZED: May 19, 2022

Civil Appeal from the Cuyahoga County Court of Common Pleas Case No. CV-20-928108

Appearances:

Ryan, LLP, Thomas P. Ryan and Daniel J. Ryan, for appellee.

Squire Patton Boggs, LLP and Colin R. Jennings, for appellant Gregory Hayslette.

Donald J. Malarcik and John P. Stiles, for appellant Frank Mazzucco.

CORNELIUS J. O’SULLIVAN, JR., J.:

Defendants-appellants, Gregory Hayslette (“Hayslette”) and Frank Mazzucco (individually “Mazzucco,” collectively “appellants”) appeal the trial court’s interlocutory order granting plaintiff-appellee’s Marilyn Williams-Salmon’s (“appellee”) motion to compel. After a thorough review of the law and facts, we affirm.

I. Procedural History and Facts This civil suit emanates from a course of treatment for appellee wherein she was prescribed prescription medication by her doctor, Deepak Raheja, M.D. (“Dr. Raheja”). It was alleged that appellee received medical treatment from Dr. Raheja between 2010-2016. Appellee claims at some point during this treatment, she was misdiagnosed with a neurological disorder known as Pseudobulbar Affect (“PBA”). Appellee maintains that she was unaware of her misdiagnosis until November 2019, when she was informed by the United States Attorney’s Office that she was a potential victim of an illegal kickback scheme. This scheme allegedly involved Avanir Pharmaceuticals, Inc. (“Avanir”) and its employees providing illegal incentives to Dr. Raheja in exchange for prescribing medications to patients, like appellee, for conditions unsupported by their presenting symptoms. Specifically, appellee contends that she was prescribed a medication called Nuedexta, which is sold by Avanir. Hayslette worked for Avanir as a pharmaceutical sales representative responsible for the marketing of Nuedexta. Mazzucco was his supervisor. Appellee alleges she suffered numerous personal injuries due to appellants’ conduct.

In 2019, appellants, among others, were charged in an 83-count indictment in federal court. The indictment alleged, among other crimes, that the appellants had violated the federal Anti-Kickback Statute, 42 U.S.C. 1320a- 7b(b)(1)(B) and 42 U.S.C. 1320a-7b(b)(2)(B).1 Appellee filed the underlying action against appellants, Dr. Raheja and Avanir, on January 21, 2020, alleging: medical malpractice against Dr. Raheja; medical battery and lack of informed consent against Dr. Raheja; negligence against all defendants; civil recovery for a criminal act, R.C. 2307.60, against all defendants; Ohio corrupt practices act, R.C. 2923.34, against all defendants; and civil conspiracy against all defendants.2 The court conducted a status conference on December 17, 2020, and ordered the parties to complete fact discovery by August 31, 2021. In December 2020, appellee filed an amended complaint, attaching an affidavit of merit pursuant to Civ.R. 10(D)(2); the amended complaint included the same parties, allegations, and prayers for relief as the original pleading. Appellee filed motions to compel discovery against each appellant in June 2021, those motions were granted by the court on September 15, 2021. This timely appeal follows.

A. The Discovery Dispute

1 In March 2022, Hayslette pled guilty to Count 1, Conspiracy to Solicit, Receive, Offer and Pay Healthcare Kickbacks in violation of 18 U.S.C. 371 and is awaiting sentencing. Trial for Mazzucco and Dr. Raheja is set for October 2022. Dr.

Raheja is not a party to this appeal.

2 In February 2020, Avanir removed the case to federal court asserting that federal court had jurisdiction under 28 U.S.C. 1331. In March 2020, appellee filed to remand the case back to state court; the court granted her motion. Williams-

Salmon v. Avanir Pharmaceuticals, Inc., N.D.Ohio No. 1:20 CV 419, 2020 U.S. Dist.

LEXIS 136347, 17 (July 31, 2020).

In March 2021, appellee issued discovery requests to both appellants, which included interrogatories, requests for production of documents, and requests for admissions.

i. Interrogatories Appellee’s interrogatories asked each appellant to identify and/or confirm:

1. Witnesses, including expert witnesses. (INT #1-2, 5)

2. Exhibits to be used at trial. (INT #3)

3. Persons who assisted appellants in preparing discovery. (INT #4)

4. Name, current and former addresses, employers. (INT #5, 8, 9)

5. Proper service of complaint. (INT #6)

6. Employment history with Avanir. (INT #10-12, 14-15)

7. Sources of income. (INT #13)

8. Statements given to Avanir or Avanir investigators. (INT #16, 19)

9. Witnesses in federal criminal case. (INT #17-18)

10. Civil and criminal case history. (INT #20-21)

11. Witness statements in connection with criminal case. (INT #22)

12. Insurance coverage and any communications with insurer.

(INT #23)

ii. Request for Production of Documents Appellee’s request for production of documents requested copies of:

1. Documents to be used in trial. (RFP #1)

2. Appellee’s medical records and bills. (RFP #2-4)

3. Appellants’ curriculum vitae. (RFP #5) 4. Expert reports. (RFP #6-9) 5. Photographs or video recordings of appellee. (RFP #10) 6. Communications among co-defendants. (RFP #11-13)

7. Communications with other named individuals, including Avanir. (RFP #14-30)

8. Contracts with Avanir. (RFP #31-33)

9. Avanir training manuals, assessments, or compliance documents. (RFP #34)

10. Reports, recordings, and video recordings related to services provided to appellee. (RFP #35)

11. Documents received from the government during appellants’ criminal matter. (RFP #36-37)

12. Payments received from Avanir. (RFP #38)

13. Insurance coverage and any communications with appellants’ insurance companies. (RFP #39-42)

14. Communication between appellants and appellee. (RFP #43)

14. Account profile sheets demonstrating the number of patients seen by Dr. Raheja from 2011 to 2016. (RFP #44)

15. Avanir’s internal investigation report and file. (RFD#45-47)

16. Documents concerning Avanir’s Speaker’s Bureau Program, including the training and communication from lawyers, managers, and compliance personnel. (RFP #47-49, 56)

17. Communications with Avanir’s compliance or legal department. (RFP #50)

18. Documents representing deleted text messages of Avanir employees. (RFP #51)

19. Government subpoenas. (RFP #52-53)

20. Notes from the September 23, 2019, meeting of Avanir’s board of directors. (RFP #54-55)

21. Documents related to and copies of various research reports and studies. (RFP #57, 59)

22. Documents related to “the criminal case in the United States District Court for the Northern District of Georgia, Criminal Action Number 1:19-CR-oo369, if any.” (RFP #58)

iii. Request for Admissions Appellee’s request for admissions asked appellants to admit to the following:

1. Admit to the authenticity of each document produced in discovery.

(RFA #1)

2. Admit that the text messages between each appellant and his co-

defendants as listed as exhibits in the criminal complaint are “true and accurate.” (RFA #2, 4, 21, 23)

3. Admit that the text messages between each appellant and his co-

defendants as listed as exhibits in the criminal complaint are authentic duplicates of the text communications. (RFA #3, 5, 22, 24).

4. Admit that payments made by appellants as listed as exhibits in the criminal complaint are “true and accurate,” that appellants made those payments or directed them to be made, and the exhibits are authentic duplicates of the amounts stated. (RFA #6 – 16, 17 – 19)

5. Admit appellants paid for dinners on the dates as listed in exhibits to the criminal complaint. (RFA #17, 20).

iv. Appellants’ Assert Fifth Amendment Privilege Appellants separately responded to each of the 116 discovery requests with substantially the same statement, which reads as follows:

Free access — add to your briefcase to read the full text and ask questions with AI

Williams-Salmon v. Raheja, 2022 Ohio 1675 (Ohio Ct. App. 2022).

2022 Ohio 1675 (Williams-Salmon v. Raheja) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

V.T. Larney, Ltd. v. Ohio Civ. Rights Comm.
2023 Ohio 3123 (Ohio Court of Appeals, 2023)